| P10636 |
TAU_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
| P10636 |
TAU_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
| P10636 |
TAU_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
| P10636 |
TAU_HUMAN |
Choreiform disorder [ICD-11: 8A01] |
| P10636 |
TAU_HUMAN |
Parkinsonism [ICD-11: 8A00] |
| P10636 |
TAU_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
| P10636 |
TAU_HUMAN |
Neurodegenerative disorder [ICD-11: 8A20-8A23] |
| P11473 |
VDR_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
| P11473 |
VDR_HUMAN |
Hair/hair growth developmental defect [ICD-11: LC30] |
| P11473 |
VDR_HUMAN |
Hyper-parathyroidism [ICD-11: 5A51] |
| P11473 |
VDR_HUMAN |
Hypo-parathyroidism [ICD-11: 5A50] |
| P11473 |
VDR_HUMAN |
Mineral deficiency [ICD-11: 5B5K] |
| P11473 |
VDR_HUMAN |
Psoriasis [ICD-11: EA90] |
| P11473 |
VDR_HUMAN |
Vitamin deficiency [ICD-11: 5B55-5B5F] |
| P11473 |
VDR_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
| P11473 |
VDR_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
| P11473 |
VDR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
| P11473 |
VDR_HUMAN |
Prostate disease [ICD-11: GA91] |
| P11473 |
VDR_HUMAN |
Abnormal micturition [ICD-11: MF50] |
| P11473 |
VDR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P11473 |
VDR_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
| P11473 |
VDR_HUMAN |
Acne vulgaris [ICD-11: ED80] |
| Q16637 |
SMN_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
| Q16637 |
SMN_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
| Q16637 |
SMN_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
| Q16637 |
SMN_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
| P08684 |
CP3A4_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P08684 |
CP3A4_HUMAN |
Atopic eczema [ICD-11: EA80] |
| P08684 |
CP3A4_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
| P43220 |
GLP1R_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
| P43220 |
GLP1R_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
| P43220 |
GLP1R_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
| P43220 |
GLP1R_HUMAN |
Type-1/2 diabete [ICD-11: 5A10-5A11] |
| P43220 |
GLP1R_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
| P43220 |
GLP1R_HUMAN |
Diabetes mellitus [ICD-11: 5A10] |
| P43220 |
GLP1R_HUMAN |
Dyspepsia [ICD-11: MD92] |
| P43220 |
GLP1R_HUMAN |
Irritable bowel syndrome [ICD-11: DD91] |
| P43220 |
GLP1R_HUMAN |
Intracranial injury [ICD-11: NA07] |
| P43220 |
GLP1R_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
| Q16236 |
NF2L2_HUMAN |
Ataxic disorder [ICD-11: 8A03] |
| Q16236 |
NF2L2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
| Q16236 |
NF2L2_HUMAN |
Glaucoma [ICD-11: 9C61] |
| Q16236 |
NF2L2_HUMAN |
Lung cancer [ICD-11: 2C25] |
| Q16236 |
NF2L2_HUMAN |
Macular degeneration [ICD-11: 9B75] |
| Q16236 |
NF2L2_HUMAN |
Melanoma [ICD-11: 2C30] |
| Q16236 |
NF2L2_HUMAN |
Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
| Q16236 |
NF2L2_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
| Q16236 |
NF2L2_HUMAN |
Subarachnoid haemorrhage [ICD-11: 8B01] |
| Q16236 |
NF2L2_HUMAN |
Urinary system clinical sympton [ICD-11: MF8Y] |
| Q16236 |
NF2L2_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
| Q16236 |
NF2L2_HUMAN |
Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
| Q16236 |
NF2L2_HUMAN |
Motor neuron disease [ICD-11: 8B60] |
| Q16236 |
NF2L2_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
| P27695 |
APEX1_HUMAN |
Retinopathy [ICD-11: 9B71] |
| P27695 |
APEX1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P27695 |
APEX1_HUMAN |
Ocular cancer [ICD-11: 2D00-2D07] |
| P27695 |
APEX1_HUMAN |
Brain cancer [ICD-11: 2A00] |
| P27695 |
APEX1_HUMAN |
Melanoma [ICD-11: 2C30] |
| Q13148 |
TADBP_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
| Q13148 |
TADBP_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
| P03956 |
MMP1_HUMAN |
Brain cancer [ICD-11: 2A00] |
| P03956 |
MMP1_HUMAN |
Lung cancer [ICD-11: 2C25] |
| P03956 |
MMP1_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
| P03956 |
MMP1_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
| P03956 |
MMP1_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
| P03956 |
MMP1_HUMAN |
Prostate cancer [ICD-11: 2C82] |
| P03956 |
MMP1_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
| P03956 |
MMP1_HUMAN |
Corneal disease [ICD-11: 9A76-9A78] |
| P03956 |
MMP1_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
| P03956 |
MMP1_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
| P03956 |
MMP1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P14780 |
MMP9_HUMAN |
Crohn disease [ICD-11: DD70] |
| P14780 |
MMP9_HUMAN |
Ischaemic/haemorrhagic stroke [ICD-11: 8B20] |
| P14780 |
MMP9_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
| P14780 |
MMP9_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P14780 |
MMP9_HUMAN |
Stomach cancer [ICD-11: 2B72] |
| P14780 |
MMP9_HUMAN |
Ulcerative colitis [ICD-11: DD71] |
| P14780 |
MMP9_HUMAN |
Brain cancer [ICD-11: 2A00] |
| P14780 |
MMP9_HUMAN |
Lung cancer [ICD-11: 2C25] |
| P14780 |
MMP9_HUMAN |
Renal cell carcinoma [ICD-11: 2C90] |
| P14780 |
MMP9_HUMAN |
Corneal disease [ICD-11: 9A76-9A78] |
| P14780 |
MMP9_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
| P14780 |
MMP9_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
| Q96KQ7 |
EHMT2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
| Q96KQ7 |
EHMT2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
| Q96KQ7 |
EHMT2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P15917 |
LEF_BACAN |
Sepsis [ICD-11: 1G40-1G41] |
| P15917 |
LEF_BACAN |
Corneal disease [ICD-11: 9A76-9A78] |
| P08253 |
MMP2_HUMAN |
Brain cancer [ICD-11: 2A00] |
| P08253 |
MMP2_HUMAN |
Lung cancer [ICD-11: 2C25] |
| P08253 |
MMP2_HUMAN |
Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
| P08253 |
MMP2_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
| P08253 |
MMP2_HUMAN |
Acne vulgaris [ICD-11: ED80] |
| P08253 |
MMP2_HUMAN |
Renal cell carcinoma [ICD-11: 2C90] |
| P08253 |
MMP2_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
| P08253 |
MMP2_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
| P08253 |
MMP2_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
| P08253 |
MMP2_HUMAN |
Prostate cancer [ICD-11: 2C82] |
| P08253 |
MMP2_HUMAN |
Corneal disease [ICD-11: 9A76-9A78] |
| P08253 |
MMP2_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
| P08253 |
MMP2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P08253 |
MMP2_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
| P08254 |
MMP3_HUMAN |
Corneal disease [ICD-11: 9A76-9A78] |
| P08254 |
MMP3_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
| P08254 |
MMP3_HUMAN |
Myocardial infarction [ICD-11: BA41-BA43] |
| P08254 |
MMP3_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
| P08254 |
MMP3_HUMAN |
Idiopathic interstitial pneumonitis [ICD-11: CB03] |
| P08254 |
MMP3_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
| P08254 |
MMP3_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
| P22894 |
MMP8_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
| P22894 |
MMP8_HUMAN |
Corneal disease [ICD-11: 9A76-9A78] |
| P22894 |
MMP8_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
| P42858 |
HD_HUMAN |
Choreiform disorder [ICD-11: 8A01] |
| P04637 |
P53_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
| P04637 |
P53_HUMAN |
Lip/oral cavity/pharynx neoplasm [ICD-11: 2B6E] |
| P04637 |
P53_HUMAN |
Metastatic liver/bile duct neoplasm [ICD-11: 2D80] |
| P04637 |
P53_HUMAN |
Transplant rejection [ICD-11: NE84] |
| P04637 |
P53_HUMAN |
Ovarian dysfunction [ICD-11: 5A80] |
| P04637 |
P53_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
| P04637 |
P53_HUMAN |
Bladder cancer [ICD-11: 2C94] |
| P04637 |
P53_HUMAN |
Brain cancer [ICD-11: 2A00] |
| P04637 |
P53_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
| P04637 |
P53_HUMAN |
Esophageal cancer [ICD-11: 2B70] |
| P04637 |
P53_HUMAN |
Head and neck cancer [ICD-11: 2D42] |
| P04637 |
P53_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
| P04637 |
P53_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
| P04637 |
P53_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
| P04637 |
P53_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
| P04637 |
P53_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P04637 |
P53_HUMAN |
Stomach cancer [ICD-11: 2B72] |
| P04637 |
P53_HUMAN |
Cervical cancer [ICD-11: 2C77] |
| P04637 |
P53_HUMAN |
Endometrial cancer [ICD-11: 2C76] |
| P04637 |
P53_HUMAN |
Fallopian tube cancer [ICD-11: 2C74] |
| P04637 |
P53_HUMAN |
Liposarcoma [ICD-11: 2B59] |
| P04637 |
P53_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
| P04637 |
P53_HUMAN |
Peritoneal cancer [ICD-11: 2C51] |
| P04637 |
P53_HUMAN |
Toxicity [ICD-11: N.A.] |
| P04637 |
P53_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P04637 |
P53_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
| P04637 |
P53_HUMAN |
Kidney failure [ICD-11: GB60-GB6Z] |
| P04637 |
P53_HUMAN |
Hearing disorder [ICD-11: AB50-AB57] |
| Q9UBN7 |
HDAC6_HUMAN |
Multiple myeloma [ICD-11: 2A83] |
| Q9UBN7 |
HDAC6_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P14679 |
TYRO_HUMAN |
Acquired hypermelanosis [ICD-11: ED60] |
| P14679 |
TYRO_HUMAN |
Acquired hypomelanotic disorder [ICD-11: ED63] |
| P14679 |
TYRO_HUMAN |
Melanoma [ICD-11: 2C30] |
| P14679 |
TYRO_HUMAN |
Acquired melanotic macule/lentigine [ICD-11: ED61] |
| P14679 |
TYRO_HUMAN |
Mineral absorption/transport disorder [ICD-11: 5C64] |
| P14679 |
TYRO_HUMAN |
Skin pigmentation genetic disorder [ICD-11: EC23] |
| P14679 |
TYRO_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
| P09917 |
LOX5_HUMAN |
Asthma [ICD-11: CA23] |
| P09917 |
LOX5_HUMAN |
Filariasis [ICD-11: 1F66] |
| P09917 |
LOX5_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
| P09917 |
LOX5_HUMAN |
Lung cancer [ICD-11: 2C25] |
| P09917 |
LOX5_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
| P09917 |
LOX5_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
| P09917 |
LOX5_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
| P09917 |
LOX5_HUMAN |
Atopic eczema [ICD-11: EA80] |
| P09917 |
LOX5_HUMAN |
Carcinoid syndrome [ICD-11: 5B10] |
| P09917 |
LOX5_HUMAN |
Fungal infection [ICD-11: 1F29-1F2F] |
| P09917 |
LOX5_HUMAN |
Idiopathic interstitial pneumonitis [ICD-11: CB03] |
| P09917 |
LOX5_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
| P09917 |
LOX5_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |
| P09917 |
LOX5_HUMAN |
Psoriasis [ICD-11: EA90] |
| P09917 |
LOX5_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P09917 |
LOX5_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
| P09917 |
LOX5_HUMAN |
Respiratory system disease [ICD-11: CB40-CB7Z] |
| P09917 |
LOX5_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
| P09917 |
LOX5_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
| P09917 |
LOX5_HUMAN |
Eczema [ICD-11: EA80-EA89] |
| P09917 |
LOX5_HUMAN |
Pruritus [ICD-11: EC90] |
| P09917 |
LOX5_HUMAN |
Thrombosis [ICD-11: DB61-GB90] |
| P09917 |
LOX5_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
| P09917 |
LOX5_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
| P09917 |
LOX5_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
| P09917 |
LOX5_HUMAN |
Malaria [ICD-11: 1F40-1F45] |
| P09917 |
LOX5_HUMAN |
Asthma [ICD-11: CA23] |
| P09917 |
LOX5_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
| P09917 |
LOX5_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
| P56524 |
HDAC4_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P56524 |
HDAC4_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| Q00987 |
MDM2_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
| Q00987 |
MDM2_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
| Q00987 |
MDM2_HUMAN |
Myeloproliferative neoplasm [ICD-11: 2A20] |
| Q00987 |
MDM2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| Q00987 |
MDM2_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
| Q00987 |
MDM2_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
| Q00987 |
MDM2_HUMAN |
Neuroendocrine carcinoma [ICD-11: 2C34] |
| Q00987 |
MDM2_HUMAN |
Liposarcoma [ICD-11: 2B59] |
| Q00987 |
MDM2_HUMAN |
Lung cancer [ICD-11: 2C25] |
| Q00987 |
MDM2_HUMAN |
Prostate cancer [ICD-11: 2C82] |
| Q00987 |
MDM2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
| Q00987 |
MDM2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| Q92769 |
HDAC2_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
| Q92769 |
HDAC2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| Q92769 |
HDAC2_HUMAN |
Eczema [ICD-11: EA80-EA89] |
| Q9BY41 |
HDAC8_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| Q9BY41 |
HDAC8_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| O15151 |
MDM4_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
| O15151 |
MDM4_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
| O15151 |
MDM4_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
| O15151 |
MDM4_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |